Autoinflammatory & rare systemic diseases
Is Satoyoshi syndrome an autoimmune disease? A systematic review
Authors' conclusion
Satoyoshi syndrome is associated with other autoimmune diseases and a variety of autoantibodies. Improvement after CS or other immunosuppressant treatment was observed in 90% of cases. These data support an autoimmune aetiology for Satoyoshi syndrome.
Study context
- Population
- Published Satoyoshi syndrome cases (PubMed, Web of Science, Scopus up to January 2022)57 articles
- Participants
- 77 cases
- Outcome
- Evidence supporting an autoimmune aetiology: symptoms, associated autoimmune diseases, autoantibodies and response to treatment
Pooled result
As reported in the abstract
- Women
- 59
- Mean age at diagnosis
- 21.2 years
- Positive autoantibodies among patients tested (39)
- 27
- Pharmacological treatment reported
- 50
- Improvement after CS or other immunosuppressant treatment
- 90%
Original publication
Is Satoyoshi syndrome an autoimmune disease? A systematic review. Rheumatology (Oxford). Published 7 February 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →